| 1. | SugarDaddy | |
| 2. | fcicco | |
| 3. | fredeugenewillia | |
| 4. | greeneyedcuddleb | |
| 5. | bigdog92ugk |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | SugarDaddy 03/16/2018 Yea.. |
| 2. | fcicco 03/16/2018 shelf offering |
| 3. | SugarDaddy 03/27/2018 Nabriva Therapeutics and Roivant Sciences Enter into License Agreement to Develop and Commercialize Lefamulin in Greater China |
| 4. | SugarDaddy 03/16/2018 big news coming? pretty high target |
| 5. | fcicco 03/16/2018 Nabriva Therapeutics Reports 2017 Financial Results and Recent Corporate Highlights |
| 6. | SugarDaddy 07/25/2018 Needham & Co. reiterates Buy rating, $18 PT |
| 7. | fcicco 03/16/2018 yah, why the triple? |
| 8. | SugarDaddy 09/18/2017 Public offering of $80.0 million of ordinary shares |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Nabriva Therapeutics AG
- NBRV
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.